cimdelirsen (IONIS-GHR-LRx) / Ionis 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cimdelirsen (IONIS-GHR-LRx) / Ionis
NCT04522180 / 2020-000675-20: A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly

Completed
2
34
Europe, US, RoW
GHR-LRX, ISIS 766720
Ionis Pharmaceuticals, Inc.
Acromegaly
07/22
05/23

Download Options